Intraductal Papillary Mucinous Neoplasm
17
5
7
6
Key Insights
Highlights
Success Rate
86% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 62/100
5.9%
1 terminated out of 17 trials
85.7%
-0.8% vs benchmark
0%
0 trials in Phase 3/4
0%
0 of 6 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 6 completed trials
Clinical Trials (17)
Intra-operative Pancreatoscopy in Patients With IPMN
Physical Activity and Nutrition to Halt Elevated Risk in the Pancreas Interception Center
Early Detection of Pancreatic Cystic Neoplasms
Intent of Surgery for IPMN
UCSF PANC Cyst Registry
Artificial Intelligence-powered Low-Dose Computed Tomography for Screening of Pancreatic Cancer
AI-powered Early Detection for Pancreatic Cancer Via Non-contrast CT in Opportunistic Screening Cohort
Oral Protein Supplements for Nutritional and Quality of Life Improvement After Pancreatic Resection in Elderly Patients
Exploring Biomarkers of the Carcinogenesis of Intraductal Papillary Mucinous Neoplasm (IPMN) of the Pancreas
Establishment of Abbreviated Pancreatobiliary MRI Protocol
SpyGlass in Preoperative Diagnostics of Presumed Main Duct IPMNs: Efficacy and Novel Insights on Complications
A Phase II MULTICENTRE Trial of Needle Based Laser Confocal Endomicroscopy of Cystic and Solid Tumours of the Pancreas
Characterization of Diabetes Mellitus in Fibrous Dysplasia/McCune-Albright Syndrome
Whole-Exome Sequencing (WES) of Intraductal Neoplasms of the Bile Duct (IPNB)
Needle-based Confocal Laser Endomicroscopy on Pancreatic Cystic Lesions
Positron Emission Tomography-computed Tomography (PET-CT) for Main & Branch Intraductal Papillary Mucinous Neoplasm
Secretin-enhanced Magnetic Resonance Imaging (S-MRI) for Pancreatic Cancer Detection